Danijela R. Lekovic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Endogenous erythroid colony formation in the era of contemporary polycythemia vera diagnosis.

Endogenous erythroid colony formation in the era of contemporary polycythemia vera diagnosis.

Journal: Expert review of hematology

Published: July 22, 2026

Comparative Value of the Novel Age-Agnostic DIPSS-R Versus the DIPSS for Prognostication in Myelofibrosis: A Multicenter Evaluation and Reclassification Study.

Comparative Value of the Novel Age-Agnostic DIPSS-R Versus the DIPSS for Prognostication in Myelofibrosis: A Multicenter Evaluation and Reclassification Study.

Journal: Cancers

Published: May 31, 2026

Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

Journal: Thrombosis and haemostasis

Published: May 13, 2026

Editorial: Differential diagnosis of erythrocytosis and analysis of their clinical utility.

Editorial: Differential diagnosis of erythrocytosis and analysis of their clinical utility.

Journal: Frontiers in medicine

Published: November 09, 2025

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications.

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications.

Journal: Journal of clinical medicine

Published: October 26, 2025

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns.

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns.

Journal: Biomedicines

Published: September 24, 2025

Longitudinal prospective analysis of organ stiffness and cardiac function in patients with myelofibrosis treated with ruxolitinib type of study: Prospective single-center cohort study.

Longitudinal prospective analysis of organ stiffness and cardiac function in patients with myelofibrosis treated with ruxolitinib type of study: Prospective single-center cohort study.

Journal: Therapeutic advances in hematology

Published: August 31, 2025

Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Journal: American journal of hematology

Published: June 23, 2025

Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methods.

Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methods.

Journal: Expert review of hematology

Published: June 16, 2025

Validation of the triple a model (age, absolute neutrophil count, absolute lymphocyte count) for the prediction of survival and thrombosis in 1000 patients with polycythemia vera.

Validation of the triple a model (age, absolute neutrophil count, absolute lymphocyte count) for the prediction of survival and thrombosis in 1000 patients with polycythemia vera.

Journal: Leukemia & lymphoma

Published: May 14, 2025

High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation.

High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation.

Journal: Frontiers in immunology

Published: February 16, 2025

Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia.

Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia.

Journal: Cancers

Published: November 04, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026